Lenalidomide (Lenalid) capsules is used with dexamethasone to treat patients with multiple myeloma who are not eligible for stem cell transplant. Multiple myeloma is a cancer of plasma cells. Plasma cells are found in the bone marrow. Plasma cells produce a protein called antibodies. Some antibodies can attack and kill disease-causing germs. Patients with this type of cancer may have low blood cell counts and immune problems giving them a higher chance for getting infections such as pneumonia. The bones can be affected leading to bone pain and breaks (fractures). Lenalidomide (Lenalid) capsules works in multiple ways within the bone marrow to stop or slow the growth of cancerous myeloma cells.
Lenalid 5/Lenalid 10: Lenalidomide (Lenalid) capsule is used in the treatment of patients who require blood transfusions due to myelodysplastic syndromes (MDS) with a chromosome problem in which part of chromosome 5 is missing. This type of MDS is known as deletion 5q MDS.
The details of how LENALIDOMIDE works in deletion 5q MDS are still being studied. When patients with deletion 5q MDS are treated with Lenalidomide (Lenalid) capsules, abnormal cells in their bone marrow are often eliminated and replaced by normal-appearing cells. Lenalidomide (Lenalid) capsule can also directly stimulate the production of red blood cells by the bone marrow. These effects can improve anemia, and reduce or eliminate the need for transfusions in patients with MDS.
Other Services
Country
Account